Clinical Trial Update: The LightPath® and 68Ga-RM2 in Breast Cancer Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for LightPath® and 68Ga-RM2 in breast cancer (Breast Cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 68Ga-RM2
• LightPath®

Snippet

Sponsor: Lightpoint Medical Limited | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN